Wells Fargo’s Vicarious Surgical RBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,618
Closed -$3.51K 7408
2025
Q4
$3.51K Buy
+1,618
New +$6.58K ﹤0.01% 6159
2024
Q3
Sell
-99
Closed -$581 7041
2024
Q2
$581 Sell
99
-1,043
-91% -$9.33K ﹤0.01% 6136
2024
Q1
$10.3K Buy
1,142
+162
+17% +$1.93K ﹤0.01% 5753
2023
Q4
$10.8K Buy
980
+418
+74% +$4.66K ﹤0.01% 5822
2023
Q3
$9.96K Sell
562
-394
-41% -$14.3K ﹤0.01% 5810
2023
Q2
$52.5K Buy
956
+527
+123% +$33.6K ﹤0.01% 5408
2023
Q1
$29.2K Buy
+429
New +$33.4K ﹤0.01% 5459
2022
Q4
Sell
-30
Closed -$3K 7670
2022
Q3
$3K Sell
30
-18
-38% -$2.1K ﹤0.01% 6075
2022
Q2
$4K Buy
48
+41
+586% +$5.01K ﹤0.01% 6113
2022
Q1
$1K Hold
7
﹤0.01% 6848
2021
Q4
$2K Buy
+7
New +$2.47K ﹤0.01% 6906

Other funds holding RBOT

Wells Fargo's RBOT Position: Q1 2026 in Review

Wells Fargo sold out of Vicarious Surgical (RBOT) in Q1 2026, closing a stake of 1,618 shares — an estimated $3.51K sold.

Wells Fargo first reported a position in RBOT in Q4 2021 and held it in 11 quarters. The position peaked at $52.5K in Q2 2023. 8 funds tracked by Wall St. Rank hold RBOT as of Q1 2026.

  • Wells Fargo reported no remaining Vicarious Surgical position as of Q1 2026 after selling out during the quarter.
  • Wells Fargo sold 1,618 Vicarious Surgical shares in Q1 2026, an estimated $3.51K.
  • Wells Fargo first reported a position in Vicarious Surgical in Q4 2021 and held it in 11 quarters.
  • Wells Fargo's Vicarious Surgical position peaked at $52.5K in Q2 2023.
  • 8 funds tracked by Wall St. Rank held Vicarious Surgical as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.